Oncology and eClinical solutions: How one company is ad...
Oncology studies present unique challenges when it comes to participant treatmen...
Ono’s TGCT therapy wins FDA approval, challenging Daiic...
Ono’s therapy Romvimza is administered twice-weekly compared to Daiichi Sankyo’s...
FDA grants fast track status to Rznomics’ RZ-001 for HCC
The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatm...